The Global Medical Bioresorbable Polymer and Material Market was valued at approximately USD 1.5 Billion in 2024 and is projected to reach USD 2.9 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of approximately 11.5% during the forecast period (2024–2030). This robust growth is driven by the rising demand for minimally invasive surgeries, the increasing prevalence of chronic diseases requiring advanced medical implants, and the accelerating adoption of bioabsorbable solutions across orthopedic, cardiovascular, and drug delivery applications.

As the healthcare industry pivots towards patient-centric solutions that eliminate the need for secondary removal surgeries, the focus intensifies on the material science innovators at the forefront. In this blog, we profile the Top 10 Companies in the Medical Bioresorbable Polymer and Material Industry—a dynamic mix of chemical giants, specialized manufacturers, and R&D pioneers shaping the future of regenerative medicine and temporary medical implants.

---

🔟 1. Evonik Industries AG

Headquarters: Essen, Germany
Key Offering: RESOMER® polymers (PLA, PLGA, PCL), custom biomaterials

Evonik is a global leader in the development and production of bioresorbable polymers, with its renowned RESOMER® brand serving as an industry standard. The company’s materials are critical components in a wide array of medical devices, including sutures, orthopedic fixation devices, and advanced drug delivery systems. Their expertise spans the entire value chain, from polymer synthesis to regulatory support.

Innovation & Growth Initiatives:

• Continuous development of novel copolymer compositions for tailored degradation profiles
• Strategic investments in manufacturing capacity expansion in the US and Asia
• Focus on high-purity, medical-grade polymers for implantable devices

Download FREE Sample Report: Medical Bioresorbable Polymer and Material Market – View in Detailed Research Report

---

9️⃣ 2. Corbion N.V.

Headquarters: Amsterdam, Netherlands
Key Offering: PURASORB® (PLA, PGA polymers), lactide monomers

Corbion is a leading producer of biobased chemicals, with a strong focus on high-purity lactic acid and its derivatives, which are the building blocks for Polylactic Acid (PLA) polymers. The company’s PURASORB® portfolio is specifically designed for demanding medical applications, offering exceptional biocompatibility and controlled resorption rates.

Innovation & Growth Initiatives:

• Vertical integration from lactic acid to high-performance PLA polymers
• Development of polymers with enhanced mechanical properties for load-bearing applications
• Commitment to sustainable and renewable raw material sourcing

---

8️⃣ 3. DSM Biomedical

Headquarters: Heerlen, Netherlands
Key Offering: bioresorbable polymers for coatings, fibers, and composites

DSM Biomedical leverages its deep polymer science expertise to create advanced biomaterial solutions. The company specializes in developing materials that support healing and regeneration, with applications in soft tissue repair, cardiovascular devices, and dental regeneration. Their materials are engineered to interact favorably with biological systems.

Innovation & Growth Initiatives:

• Focus on bioactive materials that promote specific cellular responses
• Development of resorbable composites for enhanced mechanical performance
• Strong partnership model with medical device OEMs

---

7️⃣ 4. Mitsui Chemicals, Inc.

Headquarters: Tokyo, Japan
Key Offering: LACTEL® Absorbable Polymers, PuraSorb® PL (In-house)

Mitsui Chemicals is a major player in the Asian market, offering a diverse portfolio of bioresorbable polymers through its LACTEL® brand, acquired from Durect Corporation. The company provides customized polymer solutions and technical support for drug delivery and medical device applications, backed by significant R&D capabilities.

Innovation & Growth Initiatives:

• Expansion of its high-molecular-weight PLA and PLGA portfolio
• Investment in novel polymerization technologies for better process control
• Strategic focus on the fast-growing Asian healthcare market

Download FREE Sample Report: Medical Bioresorbable Polymer and Material Market – View in Detailed Research Report

---

6️⃣ 5. PCAS

Headquarters: Longjumeau, France
Key Offering: Custom synthesis of complex molecules, pharmaceutical intermediates, and polymers

PCAS specializes in the synthesis and production of complex molecules, including key intermediates for bioresorbable polymers. The company serves the pharmaceutical and medical device industries with high-purity compounds and offers contract development and manufacturing services for specialized biomaterials.

Innovation & Growth Initiatives:

• Expertise in the synthesis of high-purity lactide and glycolide monomers
• Contract manufacturing services for custom bioresorbable polymers
• Strong regulatory support for pharmaceuticals and medical devices

---

5️⃣ 6. Poly-Med, Inc.

Headquarters: Anderson, South Carolina, USA
Key Offering: Broad portfolio of absorbable polymers, fibers, and medical devices

Poly-Med is a vertically integrated company focused exclusively on the development and manufacturing of absorbable medical polymers and finished devices. They offer a diverse range of materials, including tailored PLGA, PDS, and TMC-based polymers, and have the capability to produce everything from the raw polymer to the final sterilized device.

Innovation & Growth Initiatives:

• Proprietary polymer platforms for long-term implantable devices
• In-house device design, manufacturing, and testing capabilities
• Strong IP portfolio covering novel polymer compositions and processing methods

---

4️⃣ 7. KLS Martin Group

Headquarters: Tuttlingen, Germany
Key Offering: Bioresorbable osteosynthesis products (plates, screws, meshes)

KLS Martin is a globally recognized medical device company, particularly in the fields of craniomaxillofacial (CMF) and neurosurgery. While primarily a device manufacturer, the company possesses deep expertise in the application of bioresorbable materials, developing and marketing its own lines of resorbable implants that leverage polymers like PLA and PLLA.

Innovation & Growth Initiatives:

• Development of resorbable implants with optimized strength and degradation for CMF surgery
• Focus on user-friendly implant systems that facilitate surgical procedures
• Global distribution network serving surgeons directly

---

3️⃣ 8. International Specialty Products (ISP)/Ashland

Headquarters: Wilmington, Delaware, USA (Ashland)
Key Offering: Pharmaceutical polymers, including potential bioresorbable excipients.

While historically known for a broad specialty chemicals portfolio, the expertise in polymer science from companies like ISP, now part of Ashland, contributes to the biomaterials landscape. Their knowledge in controlled release and polymer chemistry is applicable to the drug delivery segment of the bioresorbable materials market, particularly for injectable depot formulations.

Innovation & Growth Initiatives:

• Expertise in polymer-based drug delivery technologies
• Development of biocompatible excipients for pharmaceutical applications
• Focus on creating value through material science solutions for healthcare

---

2️⃣ 9. Foster Corporation

Headquarters: Putnam, Connecticut, USA
Key Offering: Custom compounder of medical-grade polymers, including bioresorbables

Foster Corporation is a leading custom compounder of high-performance polymers for medical devices. The company works with device OEMs to develop specialized compounds using bioresorbable polymers, often creating blends or composites with specific properties like radiopacity or modified degradation rates to meet unique application requirements.

Innovation & Growth Initiatives:

• Custom compounding and masterbatching services for tailored material properties
• Expertise in ensuring regulatory compliance for implantable devices
• Technical support from material selection through to manufacturing

---

1️⃣ 10. BMG Incorporated

Headquarters: Tokyo, Japan
Key Offering: Bioresorbable polymers and contract manufacturing for medical devices

BMG Incorporated is a significant player in the Japanese market, specializing in the development and manufacturing of bioresorbable polymers and the medical devices made from them. The company has developed its own proprietary materials and technologies, focusing on applications in orthopedics and soft tissue repair.

Innovation & Growth Initiatives:

• Development of unique polymer formulations like the “Super FIXSORB” family
• Integrated business model from polymer synthesis to device manufacturing
• Strong presence in the Asia-Pacific medical device market

Get Full Report Here: Medical Bioresorbable Polymer and Material Market – View in Detailed Research Report

---

🔬 Outlook: The Future of Medical Bioresorbable Materials Is Smart and Regenerative

The medical bioresorbable materials market is undergoing a significant evolution. While first-generation materials like PLA and PGA continue to be widely used, the industry is pushing the boundaries toward next-generation functionalized biomaterials that actively participate in the healing process.

📈 Key Trends Shaping the Market:

• Development of materials with tailored degradation rates to match specific tissue healing timelines
• Integration of bioactive molecules (growth factors, antibiotics) to create “smart” implants
• Rise of 3D printing (additive manufacturing) for creating patient-specific resorbable implants
• Expansion into new therapeutic areas such as neurology and soft tissue engineering

Get Full Report Here: Medical Bioresorbable Polymer and Material Market – View in Detailed Research Report

The companies profiled above are not just supplying materials—they are enabling a paradigm shift in medical treatment, moving from permanent implants to temporary scaffolds that guide the body’s innate ability to heal and regenerate.